Negative Trials Matter: Anne Hege Aamodt Shares The TenCRAOS Trial
Anne Hege Aamodt, Member Board of Directors at European Stroke Organisation, shared on LinkedIn:
”Published today in The New England Journal of Medicine: the TenCRAOS trial.
We asked a difficult but important question: can early intravenous thrombolysis with tenecteplase improve vision after acute central retinal artery occlusion?
In this randomized phase 3 trial, the answer was no — and treatment was associated with serious safety concerns.
Negative trials matter.
TenCRAOS provides much-needed high-level evidence in a field where treatment decisions are often made under great uncertainty.
These results should inform clinical practice and future guidelines.
Deeply grateful to our multidisciplinary teams in neurology and ophthalmology for an inspiring collaboration, and to all investigators, supporters, and funders — and especially to the patients who generously participated.”
Read the full article here.
Article: A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
Authors: Stephen J. Ryan; Øystein Kalsnes Jørstad; Mona Skjelland; Maiju Pesonen; Claus Z. Simonsen; Toke Bek; Rolf Ankerlund Blauenfeldt, Anne Hege Aamodt et al., for the TenCRAOS Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 16, 2026, 19:16Maha Othman: Delighted to See Our Article Receive The Eberhard F. Mammen Most Popular Article Award 2026
-
Mar 16, 2026, 19:03Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
-
Mar 16, 2026, 18:59Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
-
Mar 16, 2026, 18:54Michael Recht Appointed Chief Medical and Scientific Advisor to NBDF’s Pathway to Cures
-
Mar 16, 2026, 18:46David McIntosh: Moving Beyond Doubts and Ensuring the Safety of Plasma Donation
-
Mar 16, 2026, 18:42Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
-
Mar 16, 2026, 18:27Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
-
Mar 16, 2026, 18:20Ahmed Koriesh: Stroke Prevention in the New 2026 ACC/AHA Dyslipidemia Guideline
-
Mar 16, 2026, 18:13Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation